Chinese biopharmaceutical firm Sinovac Biotech Ltd has dropped its plan to go public and has instead raised $86.73 million via a private placement backed by Vivo Capital and Advantech Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
